Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00734136 · ClinicalTrials.gov registry record · NA
Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome
A NA study, sponsored by Lahey Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00734136 is a NA study that was terminated before completion, run by Lahey Clinic. The registered enrollment target is 100 participants.
The verdict
NCT00734136, a NA study, was terminated before completion, sponsored by Lahey Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This Study will look at the effect of substances called "angiogenic factors"(development of new blood vessels) have on the development of severe liver disease. The results may help to understand the factors involved in the repair and regeneration of liver tissue and to see if different types of liver disease are associated with different types of factors, especially in the severe liver disease called hepatorenal syndrome.
Interventions
- PROCEDURE Blood Draws and a hepatectomy specimen
- PROCEDURE Blood draw - pre operative standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00734136
The ClinicalTrials.gov registry entry for NCT00734136 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood Draws and a hepatectomy specimen is the first listed.
NCT00734136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00734136 about?
NCT00734136 is a clinical study titled "Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome". This Study will look at the effect of substances called "angiogenic factors"(development of new blood vessels) have on the development of severe liver disease. The results may help to understand the factors involved in the repair and regeneration of liver tissue and to see if different types of live...
What is the current status of trial NCT00734136?
This trial is currently terminated. It is a NA study. The enrollment target is 100 participants. The study started on 2005-05. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00734136?
The interventions under investigation include: Blood Draws and a hepatectomy specimen (PROCEDURE), Blood draw - pre operative standard of care (PROCEDURE).
Who is sponsoring clinical trial NCT00734136?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.